New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Fighting cancer with a combination of corticosteroids and the keto diet

Fighting cancer with a combination of corticosteroids and the keto diet

byCold Spring Harbor LaboratoryIn mice with pancreatic and colorectal cancer, keto diets slow the growth of tumors, seen here in white, by a process called ferroptosis. This kills the cancer cel
Oncology January 07,2024
Fighting cancer with a combination of corticosteroids and the keto diet

Fighting cancer with a combination of corticosteroids and the keto diet

byCold Spring Harbor LaboratoryIn mice with pancreatic and colorectal cancer, keto diets slow the growth of tumors, seen here in white, by a process called ferroptosis. This kills the cancer cel
Oncology January 07,2024
Boosting anti-cancer antibodies by reducing their grip

Boosting anti-cancer antibodies by reducing their grip

byUniversity of SouthamptonIllustration of antibodies binding receptors and stimulating them. Credit: University of SouthamptonNew research from the Centre for Cancer Immunology at the Universit
Oncology January 07,2024
Boosting anti-cancer antibodies by reducing their grip

Boosting anti-cancer antibodies by reducing their grip

byUniversity of SouthamptonIllustration of antibodies binding receptors and stimulating them. Credit: University of SouthamptonNew research from the Centre for Cancer Immunology at the Universit
Oncology January 07,2024
Beating cancer-related fatigue with personalized interventions

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance
Oncology January 07,2024
Beating cancer-related fatigue with personalized interventions

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance
Oncology January 07,2024
Optimizing tobacco cessation treatment with lung cancer screening

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko
Oncology January 07,2024
Optimizing tobacco cessation treatment with lung cancer screening

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko
Oncology January 07,2024
Unique genetic signature found by research in different types of cancer

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un
Oncology January 07,2024
Unique genetic signature found by research in different types of cancer

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un
Oncology January 07,2024
Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f
Oncology January 07,2024
Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f
Oncology January 07,2024
Improving CAR T-cell and monoclonal antibody treatment through epitope editing

Improving CAR T-cell and monoclonal antibody treatment through epitope editing

by Justin Jackson , Medical XpressCredit: CC0 Public DomainIn a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published inNature, researchers at t
Oncology January 07,2024
Improving CAR T-cell and monoclonal antibody treatment through epitope editing

Improving CAR T-cell and monoclonal antibody treatment through epitope editing

by Justin Jackson , Medical XpressCredit: CC0 Public DomainIn a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published inNature, researchers at t
Oncology January 07,2024
Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

by Austrian Academy of SciencesGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111716BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instance
Oncology January 07,2024
Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

Blocking DNA production in cancer therapy by targeting the POLtheta enzyme

by Austrian Academy of SciencesGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111716BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instance
Oncology January 07,2024
Predicting condensate formation by cancer-associated fusion oncoproteins

Predicting condensate formation by cancer-associated fusion oncoproteins

bySt. Jude Children's Research HospitalOverview of the fusion oncoprotein (FO) database (FOdb). Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41655-2Many cancers ar
Oncology January 07,2024
Predicting condensate formation by cancer-associated fusion oncoproteins

Predicting condensate formation by cancer-associated fusion oncoproteins

bySt. Jude Children's Research HospitalOverview of the fusion oncoprotein (FO) database (FOdb). Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41655-2Many cancers ar
Oncology January 07,2024
New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other
Oncology January 07,2024
New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other
Oncology January 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com